Skip to Content

Physicians and Researchers Present at the 2019 American Society of Clinical Oncology (ASCO) Meeting in Chicago

May 29, 2019

UPMC Hillman Cancer Center and University of Pittsburgh physicians and researchers will be well-represented at the 2019 American Society of Clinical Oncology (ASCO) annual meeting in Chicago May 31 – June 4.  Faculty research will be featured in both oral presentations and poster sessions.


Saturday, June 1

Educational Session – 8 to 9:15 a.m.

The Management and Prevention of Anal Squamous Cell Carcinoma

Surveillance and the Management of Anal Intraepithelial Neoplasia in the HIV and Non-HIV Patient

Ian McGowan, MD, PhD, FRCP


Poster Sessions – 8 to 11 a.m.

Poster Board: #444, Abstract 10062

Morbidity and mortality in a national cohort of pediatric patients with hemophagocytic lymphohistiocytosis.

Stephen William Allen, MD


Interactive Case-Based Sessions – 4:45 – 5:45 p.m.

Many Challenges, Many Opportunities: Cancer Prevention in Patients With Multiple Risk Factors

Assessment and Management of Germline Mutations Predisposing to Breast Cancer

Phuong L. Mai, MD, MS


Poster Discussion Session – 3 to 4:30 p.m.

Poster Board: #338 • Abstract 11015

Clinical activity of pembrolizumab (P) in undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated/pleomorphic liposarcoma (LPS): Final results of SARC028 expansion cohorts.

Melissa Amber Burgess, MD


Poster Discussion Session – 4:30 to 6 p.m.

Health Services Research, Clinical Informatics, and Quality of Care

Poster Board: #210 • Abstract 6519

Quantification of the financial burden of antineoplastic agent price increases.

Michail Alevizakos, MD


Sunday, June 2

Education Session – 9:45 to 11 a.m.

Wanna Get Away? Continuous Treatments Versus Treatment Holidays in Gynecologic Cancer

Changing the Perspective for "Successful" Maintenance Therapy

Ronald J. Buckanovich, MD


Approaches to High-Risk Resected Stage II and III Melanoma

Stage II Melanoma: What Patients Are Appropriate for Adjuvant Therapy?

Jason J. Luke, MD, FACP


Poster Discussion Session – 11:15 a.m. to 12:15 p.m.

Breast Cancer—Metastatic

Poster Board: #94 • Abstract 1013

Phase II COLET study: Atezolizumab (A) + cobimetinib (C) + paclitaxel (P)/nab-paclitaxel (nP) as first-line (1L) treatment (tx) for patients (pts) with locally advanced or metastatic triple-negative breast cancer (mTNBC).

Adam Brufsky, MD, PhD


Monday, June 3

Education Session – 8 to 9:15 a.m.

Management of Uncommon and Rare Breast Cancers

Natural History and Pathology of Rare Breast Cancer Subtypes

Peter C. Lucas, MD, PhD


Poster Session – 8 to 11 a.m.

Gastrointestinal (Colorectal) Cancer

Poster Board: #68 • Abstract 3576

High incidence of advanced stage cancer and prolonged rectal bleeding history before diagnosis in young-onset patients with colorectal cancer.

Gurprataap Singh Sandhu, MBBS


Oral Abstract Session – 8 to 11 a.m.

Genitourinary (Nonprostate) Cancer

Abstract 4502: Randomized, double-blind phase III study of pazopanib versus placebo in patients with metastatic renal cell carcinoma who have no evidence of disease following metastasectomy: A trial of the ECOG-ACRIN cancer research group (E2810).

Leonard Joseph Appleman, MD, PhD


Poster Session – 1:15 – 4:15 p.m.

Melanoma/Skin Cancers

Poster Board: #142 • Abstract 9571

Association of baseline neutrophil-to-lymphocyte ratio (NLR) with response and survival in advanced melanoma (MEL) receiving PD-1 inhibitors.

Amit Hemadri, MD


Poster Board: #143 • Abstract 9572

Association of medication (Med) and antibiotic (Abx) use with response and survival in advanced melanoma (MEL) receiving PD-1 inhibitors.

Amit Hemadri, MD


Poster Board: #150 • Abstract 9579

Association of baseline body mass index (BMI) with response and survival in patients (Pts) with advanced melanoma (MEL) receiving PD-1 inhibitors.

Amit Hemadri, MD


Poster Board: #157 • Abstract 9586

A phase I study of neoadjuvant combination immunotherapy in locally/regionally advanced melanoma.

Yana Najjar, MD


Cancer Prevention, Hereditary Genetics, and Epidemiology

Poster Board: #64 • Abstract 1570

Sex-specific mortality trends in adolescents and young adults with cancer from 2007 to 2016.

Allison Close, MD


Poster Discussion Session – 4:30 to 6 p.m.

Melanoma/Skin Cancers

Peripheral Blood and Tumor Microenvironment Considerations for Immunotherapy

Jason J. Luke, MD, FACP

Discussing Abstract(s): 9515, 9516, 9517


Symptoms and Survivorship

Poster Board: #291 • Abstract 11599

Interim analyses of the efficacy of a collaborative care intervention for patients diagnosed with comorbid cancer and depression.

Jennifer Lynne Steel, PhD


Cocktail Reception


Additionally, UPMC Hillman Cancer Center will be hosting a cocktail reception at ASCO during the evening of Saturday, June 1 at the InterContinental Chicago Hotel. For more information about the event, and to RSVP, please click here.